IBDEI07A ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.3)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.3,7740,1,5,0)
 ;;=3D5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,7740,2)
 ;;=3D^127267
 ;;^UTILITY(U,$J,358.3,7741,0)
 ;;=3D204.00^^65^550^103
 ;;^UTILITY(U,$J,358.3,7741,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7741,1,4,0)
 ;;=3D4^204.00
 ;;^UTILITY(U,$J,358.3,7741,1,5,0)
 ;;=3D5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,7741,2)
 ;;=3D^267521
 ;;^UTILITY(U,$J,358.3,7742,0)
 ;;=3D204.01^^65^550^102
 ;;^UTILITY(U,$J,358.3,7742,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7742,1,4,0)
 ;;=3D4^204.01
 ;;^UTILITY(U,$J,358.3,7742,1,5,0)
 ;;=3D5^All, In Remission
 ;;^UTILITY(U,$J,358.3,7742,2)
 ;;=3D^267522
 ;;^UTILITY(U,$J,358.3,7743,0)
 ;;=3D204.10^^65^550^108
 ;;^UTILITY(U,$J,358.3,7743,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7743,1,4,0)
 ;;=3D4^204.10
 ;;^UTILITY(U,$J,358.3,7743,1,5,0)
 ;;=3D5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,7743,2)
 ;;=3D^267523
 ;;^UTILITY(U,$J,358.3,7744,0)
 ;;=3D204.11^^65^550^107
 ;;^UTILITY(U,$J,358.3,7744,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7744,1,4,0)
 ;;=3D4^204.11
 ;;^UTILITY(U,$J,358.3,7744,1,5,0)
 ;;=3D5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,7744,2)
 ;;=3D^267524
 ;;^UTILITY(U,$J,358.3,7745,0)
 ;;=3D201.90^^65^550^113
 ;;^UTILITY(U,$J,358.3,7745,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7745,1,4,0)
 ;;=3D4^201.90
 ;;^UTILITY(U,$J,358.3,7745,1,5,0)
 ;;=3D5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,7745,2)
 ;;=3D^267430
 ;;^UTILITY(U,$J,358.3,7746,0)
 ;;=3D785.6^^65^550^115
 ;;^UTILITY(U,$J,358.3,7746,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7746,1,4,0)
 ;;=3D4^785.6
 ;;^UTILITY(U,$J,358.3,7746,1,5,0)
 ;;=3D5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,7746,2)
 ;;=3D^72368
 ;;^UTILITY(U,$J,358.3,7747,0)
 ;;=3D200.20^^65^550^116
 ;;^UTILITY(U,$J,358.3,7747,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7747,1,4,0)
 ;;=3D4^200.20
 ;;^UTILITY(U,$J,358.3,7747,1,5,0)
 ;;=3D5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,7747,2)
 ;;=3D^17529
 ;;^UTILITY(U,$J,358.3,7748,0)
 ;;=3D202.00^^65^550^118
 ;;^UTILITY(U,$J,358.3,7748,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7748,1,4,0)
 ;;=3D4^202.00
 ;;^UTILITY(U,$J,358.3,7748,1,5,0)
 ;;=3D5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7748,2)
 ;;=3D^72606
 ;;^UTILITY(U,$J,358.3,7749,0)
 ;;=3D200.10^^65^550^117
 ;;^UTILITY(U,$J,358.3,7749,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7749,1,4,0)
 ;;=3D4^200.10
 ;;^UTILITY(U,$J,358.3,7749,1,5,0)
 ;;=3D5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7749,2)
 ;;=3D^175886
 ;;^UTILITY(U,$J,358.3,7750,0)
 ;;=3D273.3^^65^550^119
 ;;^UTILITY(U,$J,358.3,7750,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7750,1,4,0)
 ;;=3D4^273.3
 ;;^UTILITY(U,$J,358.3,7750,1,5,0)
 ;;=3D5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,7750,2)
 ;;=3D^73013
 ;;^UTILITY(U,$J,358.3,7751,0)
 ;;=3D203.00^^65^550^121
 ;;^UTILITY(U,$J,358.3,7751,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7751,1,4,0)
 ;;=3D4^203.00
 ;;^UTILITY(U,$J,358.3,7751,1,5,0)
 ;;=3D5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,7751,2)
 ;;=3D^267514
 ;;^UTILITY(U,$J,358.3,7752,0)
 ;;=3D203.01^^65^550^120
 ;;^UTILITY(U,$J,358.3,7752,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7752,1,4,0)
 ;;=3D4^203.01
 ;;^UTILITY(U,$J,358.3,7752,1,5,0)
 ;;=3D5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,7752,2)
 ;;=3D^267515
 ;;^UTILITY(U,$J,358.3,7753,0)
 ;;=3D238.6^^65^550^122
 ;;^UTILITY(U,$J,358.3,7753,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7753,1,4,0)
 ;;=3D4^238.6
 ;;^UTILITY(U,$J,358.3,7753,1,5,0)
 ;;=3D5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,7753,2)
 ;;=3D^81973
 ;;^UTILITY(U,$J,358.3,7754,0)
 ;;=3D205.00^^65^550^105
 ;;^UTILITY(U,$J,358.3,7754,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7754,1,4,0)
 ;;=3D4^205.00
 ;;^UTILITY(U,$J,358.3,7754,1,5,0)
 ;;=3D5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,7754,2)
 ;;=3D^267531
 ;;^UTILITY(U,$J,358.3,7755,0)
 ;;=3D205.01^^65^550^104
 ;;^UTILITY(U,$J,358.3,7755,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7755,1,4,0)
 ;;=3D4^205.01
 ;;^UTILITY(U,$J,358.3,7755,1,5,0)
 ;;=3D5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,7755,2)
 ;;=3D^267532
 ;;^UTILITY(U,$J,358.3,7756,0)
 ;;=3D205.10^^65^550^110
 ;;^UTILITY(U,$J,358.3,7756,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7756,1,4,0)
 ;;=3D4^205.10
 ;;^UTILITY(U,$J,358.3,7756,1,5,0)
 ;;=3D5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,7756,2)
 ;;=3D^267533
 ;;^UTILITY(U,$J,358.3,7757,0)
 ;;=3D205.11^^65^550^109
 ;;^UTILITY(U,$J,358.3,7757,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7757,1,4,0)
 ;;=3D4^205.11
 ;;^UTILITY(U,$J,358.3,7757,1,5,0)
 ;;=3D5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,7757,2)
 ;;=3D^267534
 ;;^UTILITY(U,$J,358.3,7758,0)
 ;;=3D289.0^^65^550^111
 ;;^UTILITY(U,$J,358.3,7758,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7758,1,4,0)
 ;;=3D4^289.0
 ;;^UTILITY(U,$J,358.3,7758,1,5,0)
 ;;=3D5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,7758,2)
 ;;=3D^186856
 ;;^UTILITY(U,$J,358.3,7759,0)
 ;;=3D238.4^^65^550^123
 ;;^UTILITY(U,$J,358.3,7759,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7759,1,4,0)
 ;;=3D4^238.4
 ;;^UTILITY(U,$J,358.3,7759,1,5,0)
 ;;=3D5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,7759,2)
 ;;=3D^96105
 ;;^UTILITY(U,$J,358.3,7760,0)
 ;;=3DV58.61^^65^550^99
 ;;^UTILITY(U,$J,358.3,7760,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7760,1,4,0)
 ;;=3D4^V58.61
 ;;^UTILITY(U,$J,358.3,7760,1,5,0)
 ;;=3D5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,7760,2)
 ;;=3DWarfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,7761,0)
 ;;=3D282.49^^65^550^88
 ;;^UTILITY(U,$J,358.3,7761,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7761,1,4,0)
 ;;=3D4^282.49
 ;;^UTILITY(U,$J,358.3,7761,1,5,0)
 ;;=3D5^Thalassemia Nec
 ;;^UTILITY(U,$J,358.3,7761,2)
 ;;=3D^329910
 ;;^UTILITY(U,$J,358.3,7762,0)
 ;;=3D289.89^^65^550^106
 ;;^UTILITY(U,$J,358.3,7762,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7762,1,4,0)
 ;;=3D4^289.89
 ;;^UTILITY(U,$J,358.3,7762,1,5,0)
 ;;=3D5^Blood Diseases Nec
 ;;^UTILITY(U,$J,358.3,7762,2)
 ;;=3D^329887
 ;;^UTILITY(U,$J,358.3,7763,0)
 ;;=3D238.79^^65^550^114
 ;;^UTILITY(U,$J,358.3,7763,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7763,1,4,0)
 ;;=3D4^238.79
 ;;^UTILITY(U,$J,358.3,7763,1,5,0)
 ;;=3D5^LYMPH/HEMATPOITC TIS NEC
 ;;^UTILITY(U,$J,358.3,7763,2)
 ;;=3D^334033
 ;;^UTILITY(U,$J,358.3,7764,0)
 ;;=3D287.30^^65^550^93
 ;;^UTILITY(U,$J,358.3,7764,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7764,1,4,0)
 ;;=3D4^287.30
 ;;^UTILITY(U,$J,358.3,7764,1,5,0)
 ;;=3D5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,7764,2)
 ;;=3D^332841
 ;;^UTILITY(U,$J,358.3,7765,0)
 ;;=3D288.09^^65^550^101
 ;;^UTILITY(U,$J,358.3,7765,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7765,1,4,0)
 ;;=3D4^288.09
 ;;^UTILITY(U,$J,358.3,7765,1,5,0)
 ;;=3D5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,7765,2)
 ;;=3D^334042
 ;;^UTILITY(U,$J,358.3,7766,0)
 ;;=3DV10.21^^65^550^56
 ;;^UTILITY(U,$J,358.3,7766,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7766,1,4,0)
 ;;=3D4^V10.21
 ;;^UTILITY(U,$J,358.3,7766,1,5,0)
 ;;=3D5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,7766,2)
 ;;=3D^295214
 ;;^UTILITY(U,$J,358.3,7767,0)
 ;;=3D284.2^^65^550^84
 ;;^UTILITY(U,$J,358.3,7767,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7767,1,4,0)
 ;;=3D4^284.2
 ;;^UTILITY(U,$J,358.3,7767,1,5,0)
 ;;=3D5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,7767,2)
 ;;=3D^334037
 ;;^UTILITY(U,$J,358.3,7768,0)
 ;;=3D202.40^^65^550^112
 ;;^UTILITY(U,$J,358.3,7768,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7768,1,4,0)
 ;;=3D4^202.40
 ;;^UTILITY(U,$J,358.3,7768,1,5,0)
 ;;=3D5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,7768,2)
 ;;=3D^69587
 ;;^UTILITY(U,$J,358.3,7769,0)
 ;;=3D58^1^65^551^80^-Cellulitis^1^1
 ;;^UTILITY(U,$J,358.3,7769,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7769,1,4,0)
 ;;=3D4
 ;;^UTILITY(U,$J,358.3,7769,1,5,0)
 ;;=3D5
 ;;^UTILITY(U,$J,358.3,7770,0)
 ;;=3D68^1^65^551^15^-Hepatitis^1^1
 ;;^UTILITY(U,$J,358.3,7770,1,0)
 ;;=3D^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7770,1,4,0)
 ;;=3D4
